共 1277 条
[1]
Tsimberidou AM(2012)Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative Clin Cancer Res Off J Am Assoc Cancer Res 18 6373-6383
[2]
Iskander NG(2010)Pilot study using molecular profiling of patients’ tumors to find potential targets and select treatments for their refractory cancers J Clin Oncol Off J Am Soc Clin Oncol 28 4877-4883
[3]
Hong DS(2014)Precision cancer medicine: the future is now, only better Am Soc Clin Oncol Educ Book 34 61-69
[4]
Wheler JJ(2009)The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation Curr Opin Genet Dev 19 230-236
[5]
Falchook GS(2007)Targeting the Raf–MEK–ERK mitogen-activated protein kinase cascade for the treatment of cancer Oncogene 26 3291-3310
[6]
Fu S(2003)BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma Cancer Res 63 3883-3885
[7]
Piha-Paul S(2006)BRAF and NRAS mutations in melanoma and melanocytic nevi Melanoma Res 16 267-273
[8]
Naing A(2013)Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas Clin Cancer Res Off J Am Assoc Cancer Res 19 3143-3152
[9]
Janku F(2006)Somatic activation of KIT in distinct subtypes of melanoma J Clin Oncol Off J Am Soc Clin Oncol 24 4340-4346
[10]
Luthra R(2010)Mutations in GNA11 in uveal melanoma N Engl J Med 363 2191-2199